April 12, 2000Nasacort® AQ, Nasal Spray
Collegeville, PA (SafetyAlerts) - The Food and Drug
Administration (FDA) today reported that Aventis is recalling Nasacort® AQ, Nasal Spray
because of super-potency (stability).
The recalled Nasacort® AQ, Nasal
Spray (Triamcinolone acetonide-16.5 grams), 120 metered acutations, is a prescription for
the treatment of the nasal symptoms of seasonal and perennial allergic rhinitis in adults
and children 6 years of age and older. (NDC #0075-1506-16.)
According to the FDA, approximately
46,000 units were distributed Nationwide and in Thailand. The recalled product bears
the Lot # MN3270 EXP 12/00. The firm estimates none remains on the market.
This ongoing Class II recall
was initiated by Aventis, by letter dated February 22, 2000. This is the first
public notice issued by the FDA.
Questions concerning this recall may
be directed to the FDA at 1-888-INFO-FDA.
FDA Recall #d-261-0
Safety Alerts compiles
comprehensive safety recall information for the United States. SafeMail is a free email
service to warn consumers of faulty products and contaminated foods. For complete
information regarding current recalls, past recalls and timely product warning
notification visit: www.safetyalerts.com.